Donald J. Griffith
Director, Outlook Therapeutics, Inc.
Companies
- Sonnet BioTherapeutics Holdings, Inc.Chief financial officer Jul 15, 2025 to now1
- Sonnet BioTherapeutics Holdings, Inc.Board member Apr 3, 2020 to now2
- Outlook Therapeutics, Inc.Board member May 12, 2016 to Nov 28, 20163
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Sonnet BioTherapeutics Holdings, Inc.0 shares4Dec 2, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Dec 2, 2025Returned to company 10,375 shares of Sonnet BioTherapeutics Holdings, Inc.4
- Jul 11, 2025Granted 10,000 shares of Sonnet BioTherapeutics Holdings, Inc.5
- Dec 11, 2023Granted 317 shares of Sonnet BioTherapeutics Holdings, Inc.6
- Feb 6, 2023Shares withheld for tax 497 shares at $1.04 of Sonnet BioTherapeutics Holdings, Inc.7
- Dec 9, 2022Granted 3,214 shares of Sonnet BioTherapeutics Holdings, Inc.7
- Apr 8, 2022Shares withheld for tax 4,507 shares at $0.37 of Sonnet BioTherapeutics Holdings, Inc.8
- Dec 15, 2021Granted 15,000 shares of Sonnet BioTherapeutics Holdings, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5SEC EDGARForm 4 filed Jul 15, 2025
- 6SEC EDGARForm 4 filed Dec 5, 2024
- 7SEC EDGARForm 4 filed Feb 17, 2023
- 8SEC EDGARForm 4 filed Apr 8, 2022